Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced vs Standard Dose Tacrolimus and MMF in De Novo Renal Transplant Recipients
NCT03968588Phase 4Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Jul 2014
- Primary completion
- Nov 2016
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in kidney transplant rejection (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Renal Graft Function (eGFR by MDRD formula) at 6 months. Started Jul 2014; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03968588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968588.